Citation: Aj. Jackson, The role of metabolites in bioequivalency assessment. III. Highly variabledrugs with linear kinetics and first-pass effect, PHARM RES, 17(11), 2000, pp. 1432-1436
Citation: Aj. Jackson et al., First measured plasma concentration value as C-max; impact on the C-max confidence interval in bioequivalence studies, BIOPHARM DR, 21(4), 2000, pp. 139-146
Authors:
Walsh, TJ
Jackson, AJ
Lee, JW
Amantea, M
Sein, T
Bacher, J
Zech, L
Citation: Tj. Walsh et al., Dose-dependent pharmacokinetics of amphotericin B lipid complex in rabbits(vol 44, pg 2068, 2000), ANTIM AG CH, 44(10), 2000, pp. 2924-2924
Authors:
McClure, ME
Hart, PM
Jackson, AJ
Stevenson, MR
Chakravarthy, U
Citation: Me. Mcclure et al., Macular degeneration: do conventional measurements of impaired visual function equate with visual disability?, BR J OPHTH, 84(3), 2000, pp. 244-250
Citation: J. Kharidia et al., Use of truncated areas to measure extent of drug absorption in bioequivalence studies: Effects of drug absorption rate and elimination rate variability on this metric. (vol 16, pg 130, 1999), PHARM RES, 16(8), 1999, pp. 1324-1324
Citation: Aj. Jackson et La. Ouderkirk, Truncated area under the curve as a measure of relative extent of bioavailability: Evaluation using experimental data and Monte Carlo simulations, PHARM RES, 16(7), 1999, pp. 1144-1145
Citation: J. Kharidia et al., Use of truncated areas to measure extent of drug absorption in bioequivalence studies: Effects of drug absorption rate and elimination rate variability on this metric, PHARM RES, 16(1), 1999, pp. 130-134
Authors:
Petitto, JM
McNamara, RK
Gendreau, PL
Huang, Z
Jackson, AJ
Citation: Jm. Petitto et al., Impaired learning and memory and altered hippocampal neurodevelopment resulting from interleukin-2 gene deletion, J NEUROSC R, 56(4), 1999, pp. 441-446